HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

P-2 (P 2)

reaction products of polymerized ascorbic acid with polymerized formaldehyde
Also Known As:
P 2; P 2 (virucide)
Networked: 723 relevant articles (29 outcomes, 48 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Valenta, Rudolf: 9 articles (10/2015 - 02/2002)
2. Hofman, Albert: 5 articles (07/2015 - 05/2010)
3. Wolmark, Norman: 5 articles (01/2015 - 06/2006)
4. Wickerham, D Lawrence: 5 articles (01/2015 - 06/2006)
5. Vrtala, Susanne: 4 articles (10/2015 - 02/2007)
6. Valent, Peter: 4 articles (05/2015 - 08/2002)
7. Hunter, David J: 4 articles (05/2015 - 05/2010)
8. Haiman, Christopher A: 4 articles (04/2015 - 05/2010)
9. Nordestgaard, Børge G: 4 articles (04/2015 - 02/2011)
10. Blackstone, Eugene H: 4 articles (11/2014 - 01/2004)

Related Diseases

1. Neoplasms (Cancer)
2. Stroke (Strokes)
3. Hypertension (High Blood Pressure)
06/01/2009 - "Hypertension control remained similar (P = .2) in both groups with cure/improvement in BP in 74% of PR and 89% of OR patients at one year. "
06/01/2014 - "Arterial mean telomere length was not associated with telomere uncapping or P53/P21-induced senescence (r = -0.02, P = 0.44 and r = 0.01, P = 0.50, respectively), but telomere uncapping was a highly influential covariate for the hypertension group difference in P53/P21-induced senescence (r = 0.62, P < 0.001, η(p)(2) = 0.35). "
01/01/2011 - "The genetic risk score, calculated as the sum of BP-increasing alleles of FGF5-rs16998073, CYP17A1-rs11191548, CYP17A1-rs1004467 and MTHFR-rs17367504, was significantly associated with increased SBP (1.16 mmHg/allele, P = 9.01E-5), DBP (0.51 mmHg/allele, P = 4.40E-4) and hypertension risk (OR = 1.22/allele, P = 2.74E-7). "
06/01/2010 - "Significant associations were replicated for 7 loci-CASZ1, MTHFR, ITGA9, FGF5, CYP17A1-CNNM2, ATP2B1, and CSK-ULK3-with any or all of these 3 traits: systolic blood pressure (P=1.4x10(-14) to 0.05), diastolic blood pressure (P=1.9x10(-12) to 0.05), and hypertension (P=2.0x10(-14) to 0.006; odds ratio, 1.10 to 1.29). "
03/01/2009 - "In 29,717 individuals, the alleles of rs5068 and rs198358 that showed association with increased circulating natriuretic peptide concentrations were also found to be associated with lower systolic (P = 2 x 10(-6) and 6 x 10(-5), respectively) and diastolic blood pressure (P = 1 x 10(-6) and 5 x 10(-5)), as well as reduced odds of hypertension (OR = 0.85, 95% CI = 0.79-0.92, P = 4 x 10(-5); OR = 0.90, 95% CI = 0.85-0.95, P = 2 x 10(-4), respectively). "
4. Ischemia
5. Infection

Related Drugs and Biologics

1. 2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosine
2. Adenosine A2A Receptor (Adenosine A2A Receptors)
3. Granisetron (Kytril)
4. Droperidol
5. Adenosine
6. Adenosine-5'-(N-ethylcarboxamide) (NECA)
7. Antigens
8. Haloperidol (Haldol)
9. Cisplatin (Platino)
10. C-Reactive Protein

Related Therapies and Procedures

1. Drug-Eluting Stents
2. Bone Marrow Transplantation (Transplantation, Bone Marrow)
3. Hysterectomy
4. Dilatation and Curettage (D&C)
5. Transplants (Transplant)